Oct-1, a member of the POU family of transcription factors, is expressed at relatively high levels in ectodermal and mesodermal cell lineages during early Xenopus embryogenesis . Here we show that overexpression of Oct-1 induces programmed cell death concomitant with the loss of the posterior part of the body axis. Truncated Oct-1 variants, missing either the C-terminal or N-terminal transactivation domain, exhibit a different capacity to cause such developmental defects. Oct-1-induced cell death is rescued in unilaterally injected embryos by non-injected cells, indicative of the non-cell autonomous character of the developmental effects of Oct-1. This was confirmed by marker gene analysis, which showed a significant decrease in brachyury expression, suggesting that Oct-1 interferes with an FGF-type signalling pathway.
Introduction
The genetic programme that controls embryonic development relies on regulation by transcription factors. The majority of known transcription factors belongs to one of several large gene families that share a homologous DNA binding domain (Mitchell and Tjian, 1989; Harrison, 1991) . One of the families of transcription factors implicated in development is that of the POU proteins (Rosenfeld, 1991; Scho È ler, 1991; Verrijzer and Van der Vliet, 1993; Herr and Cleary, 1995; Veenstra et al, 1997) . The common DNA binding motif of the family members, the POU domain, is subdivided in two subdomains, a POU-type homeodomain and a POU-specific domain. Both subdomains are indispensable for sequencespecific DNA-binding to the octamer motif ATGCAAAT, or closely related motifs (Verrijzer and Van der Vliet, 1993; Herr and Cleary, 1995) .
Many POU factor genes show a temporally or spatially restricted expression during development (He et al, 1989; Hatzopoulos et al, 1990; Rosner et al, 1990; Suzuki et al, 1990; Agarwal and Sato, 1991; Frank and Harland, 1992; Whitfield et al, 1993) . Functions during embryonic development have been established for three of the initially identified POU domain proteins , i.e. for Pit-1, Oct-2 and Unc-86 (Finney and Ruvkun, 1990; Corcoran et al, 1993; Andersen and Rosenfeld, 1994) , as well as for a number of more recently identified POU domain transcription factors Shimazaki et al, 1993; Takeda et al, 1994; Bhat et al, 1995; Nakai et al, 1995; Schonemann et al, 1995; Witta et al, 1995; Yeo et al, 1995) . Pit-1 function appeared to be critical for expression of pituitary-specific effector genes and for proliferation or survival of three anterior pituitary cell types (reviewed by Anderson and Rosenfeld (1994) ). Oct-2 proved to serve a critical function in B-cell maturation (Corcoran et al, 1993) , and the unc-86 gene product is important for lineage-dependent neuronal specification (Finney and Ruvkun, 1990) . The role of Oct-1 during development, however, has remained elusive. Oct-1 is widely (Staudt et al, 1986; Sturm et al, 1988; Scho È ler et al, 1989; Kambe et al, 1993) , though differentially expressed during development (He et al, 1989; Veenstra et al, 1995) Relatively high levels of Oct-1 protein are present in ectoderm and mesoderm of gastrula and neurula stage Xenopus embryos. During further development Oct-1 becomes progressively spatially restricted within the developing anterior central nervous system and in cranial neural crest derivatives .
Oct-1 contains several trans-activation domains that function in a promoter-selective fashion. The POU domain not only mediates sequence-specific binding to DNA, but provides surface-exposed interfaces for protein-protein interactions as well, and in some cases the POU domain suffices for transcriptional activation (Murphy et al, 1992; Tanaka et al, 1992; Luo and Roeder, 1995; Mittal et al, 1996) . In addition, both the regions N-terminal and Cterminal of the Oct-1 POU domain exhibit trans-activation activity, but these domains are differentially active, dependent on promoter context (Tanaka and Herr, 1990; Tanaka et al, 1992) .
In this paper we report on the developmental defects caused by expression of full length Oct-1 and Oct-1 variants missing either the C-terminal or the N-terminal trans-activation domain, or both. We show that Oct-1 overexpression causes enhanced apoptosis in gastrulating Xenopus embryos, which is accompanied by the loss of posterior structures of the body axis. We have characterised the early spatio-temporal pattern of both endogenous and Oct-1-induced programmed cell death (PCD) in the amphibian embryo. The induced PCD appears to initiate concomitant with the appearance of endogenous apoptosis. In addition, the data indicate that both PCD and the loss of posterior structures are mediated by a non-cell autonomous mechanism, and marker gene analysis suggests that it involves impaired signalling of a member of the FGF-family of growth factors.
Results

Oct-1 overexpression causes apoptosis and posterior deletions
We previously reported the spatio-terminal distribution of Oct-1 RNA and Oct-1 protein during Xenopus embryogenesis, as a first step towards the elucidation of the role of this transcription factor . To test if altered expression of Oct-1 would disturb embryonic development, overexpression experiments were performed. Expression of full length Oct-1 by injection of in vitro synthesized capped RNA into zygotes perturbs embryonic development, starting at gastrulation, whereas injection of antisense control RNA has no effect. Development of Oct-1 overexpressing embryos is normal during cleavage stages. At gastrula stage 10, the dorsal blastopore lip is thicker and it slightly diverges from the yolk plug, resulting in a pit between the dorsal blastopore lip and the yolk plug. During subsequent development ( Figure 1F ± H), the internal gastrulation movements are abnormal, the archenteron is absent ( Figure 2C ), and cells detach from the dorsal blastospore lip (Figures 2C and 3A ± B) , which causes a cleft between the yolk plug and the dorsal blastospore lip. The embryos become covered by detached cells that accumulate within the vitelline membrane ( Figures 1H, I and 2C), and continue developing until at least tadpole stages. Tail development however, is severely affected; in a significant proportion of injected embryos (see below) the tail is rudimentary ( Figures 1I ± K and 2D) . Development of the head and trunk is retarded, but the proportions and gross morphology of these structures is relatively normal in most embryos ( Figure 2D ). The minor abnormalities observed in the anterior part of the embryo during later development were either not fully penetrating or could easily represent indirect effects of earlier perturbations. Increasing the dose of injected RNA results in an increase of the number of dissociated cells, incidently but not typically leading to complete dissociation of the gastrula embryo and cessation of embryonic development.
The dissociated cells received and translated the injected RNA, which was assessed both by co-injection of LacZ RNA and subsequent b-galactosidase staining, and by immunohistochemistry ( Figure 3A , B).
At this point various interpretations were possible, for example the cells that are lost by dissociation at and around the dorsal blastopore lip during the second half of gastrulation, might normally give rise to the posterior part of the embryo, as early involuting cells acquire an anterior specification . Alternatively, impaired posterior specification might result in cell dissociation or apoptosis. As a first step to explore several of these possibilities, we characterised the nature of the cell dissociation observed. The experimental data suggested that the cause of cell dissociation might involve programmed cell death (PCD). The dissociated cells exhibit cytoplasmic Oct-1 staining, and the nucleus is not detected in those cases with a DNA binding fluorescent dye ( Figures  2C and 3B ). The loss of nuclei is an early event (mid gastrulation stages), and cell lysis is a late (late tailbud stages), apparently secondary, event in affected cells. This sequence of events has been associated with apoptosis in some cell types (Dini et al, 1996) . Therefore, the nuclear morphology was studied in antisense and Oct-1 RNA injected gastrula stage embryos (Figure 3 ). In sense RNA injected embryos, but not in normally developing antisense RNA injected embryos, nuclear condensation and fragmentation was observed in stage 10 gastrula stage embryos ( Figure 3G ). During subsequent development, the nucleus is lost in the absence of cell lysis, and nuclear Oct-1 protein is observed in the cytoplasm ( Figure 3E and H). The temporary absence of Oct-1 staining signals in the fragmented apoptotic nuclei ( Figure 3D ) probably reflects changes in nucleoprotein organisation and antibody accessibility concomitant with nuclear condensation, as the protein is easily detected in the cytoplasm once the nucleus is lost ( Figure 3E and H). Concordant with the dissociating cells being apoptotic, both in situ TUNEL (TdT-mediated dUTP nick end labelling) analysis, and cell death ELISA experiments indicated increased levels of PCD in Oct-1 overexpressing cells.
Oct-1-induced apoptosis is not caused by perturbed gastrulation and is rescued by non-overexpressing cells
We characterised the specificity of the Oct-1-induced phenotype in more detail. Cleavage and the initiation of gastrulation proceed normally (Figure 1) . Therefore, Oct-1 DNA binding activity was examined in blastula stage extracts of Oct-1 RNA injected embryos. Though it is not causing any effect or perturbation, ectopic Oct-1 appears to be abundantly present already at the blastula stage (gel shift analysis, data not shown). In addition to the antisense RNA control, which is inert in the Xenopus embryo, we have found that some Oct-1 deletion mutants do not cause apoptosis ( Figure 5) ; one of these (designated Oct-1 NP) binds DNA and contains a well documented Herr, 1990, 1994; Seipel et al, 1992; Tanaka et al, 1992; Das et al, 1995) N-terminal trans-activation domain.
We also addressed the possibility that apoptosis results from nonspecific perturbation of gastrulation. If this were the case, the prediction would be that unhealthy embryos, showing spontaneous gastrulation defects, show increased levels of PCD. This, however, is not the case. Though cells indeed detach from these embryos, these defects are not accompanied by increased levels of apoptosis ( Figure 4A ), indicating that eventual cell death or necrosis later on in development is not a primary, but rather an indirect effect. The specificity of this early apoptosis observed here implies that perturbed gastrulation and cell dissociation not necessarily cause apoptosis, and the Oct-1-induced gastrulation phenotype might be caused by (rather than being causal for) PCD.
Neither the injected RNA nor its encoded product are toxic by itself, because if the amount of RNA (0.3 fmole) that causes a significant increase of cell death when injected in the one-cell zygote, is injected into a single blastomere of the 8-cell stage embryo, no increased cell death is observed, as shown with cell death ELISA ( Figure  4B ) and in situ TUNEL experiments (data not shown). Apparently Oct-1-induced cell death is rescued by the presence of cells that do not overexpress Oct-1, and Oct-1 , and Oct-1 PC RNA injected St. 12 embryo (E). The recording settings were different for C because of the relatively low levels of endogenous Oct-1 protein present in the embryo. (F ± H) Nuclear morphology as observed by labelling with the DNA binding dye BOPRO-3. DNA-and Oct-1 labelling were performed simultaneously (compare C ± E with F ± H). Bar in F: 10 mm. Arrows in G: highly condensed DNA overexpression is not sufficient to induce PCD in a cellautonomous manner. Micro-injection of RNA into two bilateral blastomeres of the 8-cell stage embryo does moderately increase programmed cell death in some embryos as detected by in situ TUNEL analysis (data not shown), in contrast to injections into only one blastomere. The most straightforward interpretation is that Oct-1 down regulates a secreted signal, which then, in the absence of cells providing the signal, causes PCD.
Oct-1 domains that cause posterior deletions
In order to identify the Oct-1 domains that mediate the functional interactions that disturb embryonic development, a series of Oct-1 variants was constructed by deleting the Nterminal domain, or the C-terminal domain, or both ( Figure  5A ). These Oct-1 variant proteins were expressed in Xenopus embryos by injection of equimolar amounts of in vitro synthesised capped RNA into zygotes. The relative abun- Figure 4 (A) Spontaneous gastrulation defects are not associated with increased PCD. Cell death was assayed by in situ Tdt-mediated dUtp nick end labelling (TUNEL) labelling (A, left and right inset) and with an ELISA assay that detects low molecular weight nucleosomal DNA in cytoplasmic extracts (A, below inset). Gastrula stage embryos, injected at the one-cell stage with 0.3 fmole of either antisense RNA or Oct-1 PC RNA, from both normal batches and from batches exhibiting spontaneous gastrulation defects, were subjected to these techniques. Embryos derived from batches exhibiting spontaneous gastrulation defects show no increase in PCD when injected with antisense RNA (first bar and upper left inset, note dissociated cells in the absence of TUNEL staining) when compared to antisense RNA injected embryos derived from healthy batches (second bar). Unhealthy embryos show a decreased ability to rescue Oct-1-induced effects (third en fourth bar) concordant with a decreased number of cells contributing to secretion of a putative rescuing signalling factor (B). Cell death ELISA was applied to stage 12 embryo extracts, upper panel left represents an antisense RNA injected stage 10 embryo from a batch showing spontaneous gastrulation defects, upper panel right represents a stage 12 Oct-1 PC RNA injected embryo from a normal batch. (B) Oct-1-induced PCD is rescued by non-expressing cells. Oct-1 PC RNA (0.3 fmole) was injected into one-cell zygotes and into one blastomere of 8-cell morula embryos. The extent to which PCD was induced was determined at stage 12 by cell death ELISA. a-d, animal-dorsal; a-v, animal-ventral; v-d, vegetal-dorsal; v-v, vegetal-ventral; 1-c, one cell stage embryo To compare the ability of Oct-1 variants to induce posterior truncations, embryos injected with equimolar amounts of RNA encoding these variant proteins, were classified using a Posterior-deleted Index, which is a modified Head ± Tail Index (A.J. Durston, personal communication). In this Posterior-deleted Index (PI), normal embryos are classified as 0. Embryos which are only slightly curved are also classified as normal, since a slight curvature is often an injection artefact. Embryos with a reduced, but morphologically normal tail, embryos with a strongly curved, or U-shaped tail of normal length, and embryos with a reduced, split tail, are classified as PI 1. Embryos with a curled tail exhibiting severe lateral tissue deletions, and embryos with a rudimentary tail are classified as PI 2. Embryos in which both posterior and anterior structures are affected, are classified as PI 3, since a lack of anterior structures represents the most severe posterior truncation possible.
RNA was injected at doses of 0.3, 0.75, and 1.5 fmole per embryo, and embryonic phenotypes were classified with the Posterior-deleted Index as detailed above (see Figure 5 and Table 1 ). Injection of antisense RNA does not perturb development (average PI=0.3 at 1.5 fmole RNA, see Figure  5C ), as expected, since this RNA does not change the amount of endogenous DNA binding competent Oct-1 (data not shown). NPC Oct-1 causes a significant increase in the average PI ( Figure 5C ). NP, in contrast to NPC, does not induce phenotypic deletions, although NP is expressed at higher levels than NPC ( Figure 5B ). In contrast, Oct-1 PC readily induces posterior truncations, although it is less well expressed compared to NP. Embryos are more sensitive to Oct-1 PC than to Oct-1 NPC; although protein levels are similar under these conditions, PC induces more severe phenotypes. Furthermore, at 0.75 fmole RNA per embryo and at smaller amounts of RNA per embryo, the ability to induce phenotypic aberrations is much lower for NPC than for PC (Table 1 and data not shown). Expression of the POU domain alone (P) also induces posterior defects ( Figure 5C ). P protein, however, is relatively abundant under these conditions ( Figure 5B ), and at RNA doses lower than 0.75 fmole per embryo, P does not show effects on embryonic development, while PC does (data not shown), indicating that embryos are more responsive to PC than to P.
We examined whether the Oct-1 DNA binding domain, the POU domain, is required for phenotype induction. Injections of RNA encoding the N-terminal domain alone (N), did not increase the PI (data not shown), similar to the result obtained with injections of Oct-1 NP RNA. If, however, the induction of phenotypic alterations was induced via a DNA binding independent mechanism, the C-terminal activation domain alone (C) might possess part of the activity of PC, like P contains part of the activity of PC. Injection of C RNA, however, does not result in an increased Posterior-deleted Index ( Figure 5C ).
The relative contribution of Oct-1 domains to the induction of apoptosis as detected by the presence of low molecular weight nucleosomal DNA in the cytoplasm during gastrulation, yielded similar results. Cytoplasmic extracts of gastrula stage 10 and stage 12 embryos were tested using a sandwich ELISA with anti-histone and anti-DNA antibodies. Nucleosomal DNA is detected in the cytoplasm of stage 12 embryos expressing Oct-1 NPC, PC or P. In contrast, antisense RNa, Oct-1 NP and C do not induce apoptosis in gastrulating Xenopus embryos ( Figure 5D ). The extent to which apoptosis is induced correlates tightly with the average Posterior-deleted Index of embryos injected with the respective RNA ( Figure 5C and D) .
In conclusion, embryonic cells are most responsive to Oct-1 PC, to a lesser degree to Oct-1 P and NPC, and under the conditions tested, the cells are not responsive to antisense RNA, Oct-1 NP, or C. Therefore, the cell death and increased PI caused by Oct-1 are critically dependent on the POU domain, whereas the C-terminal and N-terminal activation domains respectively contribute to and inhibit programmed cell death and the loss of posterior structures when fused to the POU domain. These data identify the Oct-1 domains that contain the relevant information interfaces for selective protein-DNA and protein-protein contacts on the target promoters that are involved.
Spatio-temporal pattern of endogenous and Oct-1-induced cell death
To explore the potential relationship between the Oct-1-induced PCD and the endogenous death programme, we characterised the spatio-temporal PCD pattern in normal and Oct-1-injected embryos by in situ TUNEL analysis. As assessed with this technique, endogenous programmed cell Oct-1 in Xenopus embryos GJC Veenstra et al death appears between stage 10 and 11 in a scattered pattern in epidermal ectoderm, whereas neurectoderm, mesoderm or endoderm show negative ( Figure 6A , B). Apoptosis-positive cells are identified as cells with nuclear or cytoplasmic staining; these differently labelled cells represent respectively early and progressed stages of cell death and nuclear degradation. The number of apoptosis-positive cells increases during gastrulation, then remains constant until tailbud developmental stages ( Figure 6C ), after which the apoptotic rate increases dramatically (data not shown). The primary target of apoptosis during early Xenopus development apparently is the epidermis, like it is in Drosophila (Abrams et al, 1993) . During later development, cells in other tissues of the embryo, including the somites and the central nervous system, start to undergo apoptosis (not shown, compare Chen et al (1994) ; Blaschke et al (1996) ). Oct-1 overexpression induces ectopic programmed cell death near the blastopore in meso-and endoderm, and increases the number of apoptotic cells in ectoderm, concomitant with the appearance of endogenous cell death ( Figure 6D ± E). Overexpression-induced apoptosispositive cells exhibit cytoplasmic TUNEL staining, indicative of a progressed stage of cell death in stage 10 ± 11 already. The increase of apoptosis following injection of RNA encoding Oct-1 variants (PC and P) is also detected with in situ TUNEL analysis (data not shown), concordant with the results obtained with the cell death ELISA ( Figure 5 ).
No increase in cell death is observed following injection with antisense or Oct-1 C RNA.
Marker gene expression
The observation shown in Figure 4B suggests that normal cells secrete a signal which rescues cell death in Oct-1-overexpressing cells. Oct-1 overexpression may interfere with this signal, causing cells, in the absence of the signal emanating from neighbouring cells, to undergo PCD. We examined the expression of a series of marker genes in order to characterise the molecular changes brought about by Oct-1 expression.
Brachyury (Xbra) gene expression was examined as a downstream target of FGF signalling (Isaacs et al, 1994) . Interestingly, expression of a dominant-negative FGF receptor mutant causes an embryonic phenotype bearing similarity to the Oct-1 phenotype (Amaya et al, 1991) . In addition, FGF signalling has been implicated in anteroposterior pattern formation in a pathway that involves Hox genes (Isaacs et al, 1992; Pownall et al, 1996) . As shown in Figure 7 , Xbra expression is down-regulated in early gastrula stage embryos injected with Oct-1 PC RNA, whereas a small decrease is observed in Oct-1 NPC RNA injected embryos. A number of other genes, including the eFGF, XRb (retino- Figure 7 The Xbra gene is down-regulated in Oct-1 injected embryos. RNA was isolated from early gastrula stage (stage 10) embryos that were noninjected (control, lane 1), or injected with 1 fmole of Oct-1 antisense RNA (lane 2), Oct-1 NPC RNA (lane 3), or Oct-1 PC RNA (lane 4). The RNA samples were analyzed by Northern blotting. Actin hybridization serves as RNA loading control. The RNA loading-corrected abundance of Xbra mRNA in Oct-1 NPC and Oct-1 PC RNA injected embryos is respectively 70% and 32% relative to that observed in control embryos. The observed effects on Xbra expression are consistent between experiments, and the quantitation is based on two independent sets of injection experiments blastoma), Xwnt-5C, and actin genes do not show any change in expression level in these embryos (Figure 7 and data not shown). This result suggests that FGF-signalling is down-regulated in Oct-1 injected embryos. Importantly, the change in Xbra expression level occurs at a developmental stage at which neither PCD nor any morphological effects are apparent in the embryo.
Discussion
Oct-1 is known as a widely expressed transcription factor with a role in the regulation of house keeping genes like the histone H2B and snRNA genes (Mattaj et al, 1985; Staudt et al, 1986; Fletcher et al, 1987; LaBella et al, 1988; Sturm et al, 1988; Murphy et al, 1989; Parry et al, 1989; Scho È ler et al, 1989; Heintz, 1991; Perry, 1991, 1992; Danzeiser et al, 1993; Kambe et al, 1993) . Previous work has shown that Oct-1 is differentially expressed during early development in a pattern distinct from overall cell density or cell proliferation , prompting us to explore developmental functions of this transcription factor by perturbing its expression. In this paper we present some of the results which, in addition to establishing the early spatio-temporal pattern of endogenous apoptosis in the Xenopus embryo, and assessing Oct-1 activation domain function in vivo, implicate regulated Oct-1 expression in the expression or function of a signalling factor essential for gastrulation. Impaired production of this putative activity results in increased levels of apoptosis and posterior deletions.
Spatio-temporal pattern of endogenous apoptosis in Xenopus
Recently Stack and Newport reported data that suggest a model in which a functional apoptotic pathway in the early cleaving embryo is suppressed by maternally contributed inhibitors (Stack and Newport, 1997) . Experiments in which embryos were treated with hydroxyurea during different time intervals indicated that during an early gastrula transition (EGT) negative regulation of an otherwise default apoptosis pathway is transferred from maternal to zygotic control (Stack and Newport, 1997) . This transition coincides with the developmental stage at which we identify the initiation of both endogenous and Oct-1-induced apoptosis. This suggests that the zygotic inhibitors of apoptosis expressed between the midblastula transition (MBT, when zygotic transcription starts) and the EGT are different from, or less abundant than the maternal inhibitors. The early spatio-temporal pattern of endogenous PCD, as established in this report, may well be regulated by the zygotic control mechanism Stack and Newport (1997) identified with hydroxyurea experiments.
Down-regulation of brachyury expression
Concordant with down-regulation of Xbra transcripts as a key to the developmental effects of Oct-1 overexpression are the similar morphological effects of dominant-negative FGF receptor (XFD) expression (Amaya et al, 1991) . XFDexpressing embryos exhibit a normal onset of gastrulation, but fail to complete gastrulation normally. The dorsal axis does not form normally resulting in dorsally bent embryos (compare Figure 1J ). Embryos at tadpole stages have heads but little or no tail (compare Figure 1K) . The dominantnegative FGF receptor appears to interfere with the formation of posterior and lateral mesoderm (Amaya et al, 1991) . One of the FGFs expressed in the early Xenopus embryo, eFGF, upregulates Xbra expression (Isaacs et al, 1994) , and is involved in a molecular pathway that establishes the antero posterior axis, which also involves Xcad3 and Hox genes (Pownall et al, 1996) .
Whereas the whole embryo and individual blastomere injections excluded a cell-autonomous mechanism underlying the effects brought about by Oct-1 overexpression, and the down-regulation of Xbra expression suggested the involvement of an FGF-type signalling factor, eFGF expression appears to be unaffected (data not shown). One of the hypotheses to test is that Oct-1-induced misexpression of another member of the FGF family of growth factors is involved in down-regulation of Xbra. Future studies will address the identify of the signalling activity down-regulated by Oct-1 in our studies, and the mechanism underlying the developmental effects.
Octamer binding transcription factors are known to interact with the HMG box factor Sox2 on the FGF-4 enhancer of the mouse (Dailey et al, 1994; Yuan et al, 1995) . Neither Sox2 nor Oct-1 or Oct-3 can activate this enhancer on its own. The cooperative binding of Sox2 and Oct-3 results in synergistic activation of the FGF-4 gene, whereas the Sox2 ± Oct-1 combination does not activiate. Oct-1 may therefore downregulate the enhancer by competition with Oct-3 for cooperative Sox2-enhancer binding. If these interactions operate on a homologous enhancer in Xenopus, this would provide a mechanism for the non-cell autonomous induction of apoptosis and down-regulation of Xbra in Oct-1 RNA injected embryos. Though it is clear that Oct-1 inhibits the expression or function of a signalling factor that is required for Xbra expression, it is not clear to what extent other POU domain transcription factors are capable to exert the same (or opposite) effects. The in vivo regulation may depend on a variety of transcription factors that compete for cis-acting elements and that together orchestrate the spatio-temporal expression pattern of the target genes (see for review Veenstra et al (1997) ).
Oct-1 interaction interfaces mediating an apoptotic response and Xbra down-regulation
We have observed unique functions for the Oct-1 activation domains; whereas the C-terminal activation domain contributes to the POU domain's ability to induce apoptosis and posterior deletions, the N-terminal activation domain fails and rather inhibits the POU domain's ability to do so ( Figure 5 ). Both the N-terminal and C-terminal domains of human Oct-1 contain well defined trans-activation domains (Tanaka and Herr, 1990; Seipel et al, 1992; Tanaka et al, 1992; Das et al, 1995) . We have tested the highly homologous N-terminal and C-terminal activation domains of Xenopus Oct-1 for activation properties. Both activation domains are capable of activating the Xenopus snail promoter, as tested by co-injecting RNA encoding the Oct-1 deletion variants with snail promoter reporter constructs (data not shown). It is well-known though, that the relative activation properties of Oct-1's N-and Cterminal domains are highly promoter-context dependent. For example, the N-terminal trans-activation domains of Oct-1 and Oct-2 can functionally replace one another when tested on the b-globin promoter. However, an Oct-2 C-terminal transactivation domain is required together with either one of these N-terminal domains to activate this promoter (Tanaka and Herr, 1990) . In contrast, activation of the U2 snRNA promoter requires an Oct-1 C-terminal domain-type activation domain; Oct-2 cannot activate this promoter because of its different Cterminal activation domain (Tanaka et al, 1992) . In the context of another promoter, that of the thyrotropin (TSH) b gene, the C-terminal domain of Oct-1 exhibits silencing activity (Kim et al, 1996) . In addition to serving as a DNA binding domain, the POU domain has been reported to mediate protein-protein interactions (LeBowitz et al, 1989; Ingraham et al, 1990; Verrijzer et al, 1992; Zwilling et al, 1994 Zwilling et al, , 1995 Bach et al, 1995; Gstaiger et al, 1995; Leger et al, 1995; Luo and Roeder, 1995; Strubin et al, 1995) , and in a number of cases the POU domain alone suffices for trans-activation (Murphy et al, 1992; Tanaka et al, 1992; Luo and Roeder, 1995; Mittal et al, 1996) . In conclusion, which Oct-1 domains contribute to a certain transcriptional response is highly dependent on the context of the promoter mediating that response. As far as the induction of apoptosis and posterior deletions in the embryo are concerned, the POU domain and the C-terminal activation domain appear to provide the interaction interfaces that mediate these in vivo effects.
Differential expression and protein-protein interactions as a key to developmental control of gene expression
Whereas future experiments need to characterise the molecular basis of the developmental effects brought about by Oct-1, it is clear from both expression data and functional data that Oct-1 function is not merely restricted to house keeping gene regulation. Conceptually, there are two mechanisms by which a widely expressed transcription factor like Oct-1 contributes to developmental gene regulation: differential expression and protein-protein interactions. In Xenopus embryos, Oct-1 protein levels differ at least sixfold between cells in different parts of the embryo . In addition, protein-protein interactions often provide a major key to establishing cell type-specific expression patterns during embryonic development (Goodrich et al, 1996; Gray and Levine, 1996; Hanna-Rose and Hansen, 1996) . For example, protein-protein interactions mediated by POU domain proteins lead to either synergistic activation or transcriptional repression of target genes in cells where the interacting transcription factors are co-expressed. In either case, these interactions contribute to establishing spatially restricted patterns of gene expression (reviewed in Veenstra et al (1997) ). The fact that cell type-specific expression of many genes is determined by the relative abundance of transcriptional activators and repressors, and by promoterselective protein-protein interactions mediated by these regulators, explains that, in some cases, target genes are spatially more confined in their expression than the regulators that confer this spatial restriction of expression. Furthermore, it provides a mechanism for the appearance of increasingly specialised programmes of gene expression that are established concomitant with successive induction and differentiation events during embryonic development. It, moreover, may provide a solid conceptual basis to explain specialised developmental roles played by widely but differentially expressed transcriptional regulators such as Oct-1. We anticipate that identification of the putative downregulated FGF factor, and elucidation of the mechanism of its regulation by Oct-1 and other octamer factors, will reinforce the complexity of the spatio-temporal control of gene expression in the embryo.
Materials and Methods
Constructs and RNA synthesis
Capped RNAs were synthesised from 3' linearised pT7TS-derived Oct-1 constructs (pTO constructs) using an in vitro RNA synthesis kit (Ambion). pT7TS was kindly provided by Dr. P. Krieg. pTO-NPC was obtained by cutting pLLB/XOct1 with HindIII and EcoRI, filling in the sticky ends of the 2550 bp Oct-1 fragment, and ligation of this fragment in the EcoRV site of pT7TS. This cloning procedure also yielded a pT7TS construct containing the NPC insert in the reverse orientation. The latter construct was used for synthesis of antisense RNA. The other pTO constructs were constructed using standard procedures with ATG start codons naturally occurring in the Oct-1 cDNA, except in the pTO-P and pTO-PC constructs where an ATG start codon was introduced by PCR.
Microinjection
RNA was injected in fertilised dejellied eggs at equimolar amounts. 0.75 fmole RNA corresponds to respectively 703 pg antisense RNA, 703 pg NPC RNA, 418 pg NP RNA, 510 pg PC RNA, 215 pg P RNA, 405 pg C RNA. For promoter analysis, 50 pg pXSna-Luc and 50 pg b-actin-CAT (Schoorlemmer et al, 1994) , and 0.75 fmole Oct-1 RNA was co-injected. In most experiments, injections were made in the animal half of the embryo during the first cell cycle of the embryo. Embryos were injected in 3% ficoll in 25% MMR buffer (Peng, 1991) , which was replaced by 25% MMR buffer at stage six of development. Embryos were incubated overnight at 148C or 178C depending on the required stage of analysis. LacZ RNA injected embryos were assayed for b-galactosidase activity as described (Koster et al, 1996) .
Electrophoretic mobility shift assays (EMSA)
EMSA experiments were performed as described before . Briefly, 10 ± 20 embryos were homogenised in 20 ± 40 ml whole cell extract buffer (WCE buffer: 25 mM Tris-HCl pH 8, 400 mM KCl, 1 mM EDTA, 20% glycerol, 5 mM DTT, 1 mg ml 71 pepstatin, 1 mg ml 71 leupeptin). 2 ml of extract was incubated with a 19 base pair 32 P-end-labelled double stranded oligonucleotide containing the Ad4 octamer site (Verrijzer et al, 1990) , in a 20 ml binding reaction as previously described . In case fewer embryo equivalents per reaction were required, the appropriate amount of extract was supplemented with WCE buffer to 2 ml. The protein-DNA complexes were loaded onto a 6% non-denaturing polyacrylamide gel. Gels were run for 3 h at 150 V at 48C, dried under vacuum and subjected to autoradiography. Quantitation of Oct-1/DNA complexes was performed using a Phosphor Imager (Molecular Dynamics).
Immunohistochemistry and DNA staining
Albino Xenopus embryos, staged according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967) , were collected and fixed as described . Oct-1 immuno labelling was performed as described Veenstra et al, 1995) using an antimouse antibody conjugated to the fluorescent dye Cy5 (Jackson Immunoresearch Laboratories). Staining of nuclei was performed using the DNA binding fluorescent dye BOPRO-3 (Molecular Probes) diluted 1 : 1000 (1 mM stock solution) in wash buffer during the first wash following the secondary antibody incubation.
Cell death detection
For detection of nucleosomal DNA in the cytoplasm of Xenopus embryos, a cell death detection ELISA (Boehringer Mannheim) was used. Cytoplasmic extracts were prepared as follows. Extracts were made of five embryos. The embryos were washed in 25% MMR buffer (Peng, 1991) . Excess buffer was removed, and 50 ml incubation buffer (Boehringer) was added. Lysis was obtained by gently pipetting up and down. 10 ml of this lysate was diluted with 190 ml incubation buffer (Boehringer), and the diluted lysate was incubated for 30 min on ice. The extracts were subsequently centrifuged for 10 min at 48C in a bench top eppendorf centrifuge at maximal speed. 160 ml of supernatant was removed, carefully avoiding pellet contamination. The ELISA then was performed according to the manufacturer's protocol. In situ TUNEL (Tdt-mediated dUTP nick end labelling) analysis was performed in whole mount essentially as described (Blaschke et al, 1996) , with a few adaptations. Briefly, embryos were fixed in 4% paraformaldehyde, stored in methanol, and rehydrated as described for immunohistochemical procedures Veenstra et al, 1995) . Vitelline membranes were either removed before fixation, or carefully pierced with a pair of forceps before starting the reaction. Embryos were incubated for 30 min in TdT buffer (Life) at room temperature; subsequently the embryos were labelled overnight at room temperature with 150 U ml 71 TdT (Life) and 0.5 mM digoxygenin-labelled dUTP (Boehringer-Mannheim). The reaction was terminated by incubation for two times 1 h in phosphate buffered saline (PBS) containing 1 mM EDTA, at 658C. This was followed by four times 1 h incubation in PBS at room temperature, and labelling of incorporated digoxygenin using alkaline phosphatase-conjugated anti-digoxygenin Fab fragment, according to established procedures (Harland, 1991) . The chromogenic reaction was allowed to continue for 1 to 2 h.
